AF12198 – Immunology – Antigens/Epitotes/Pools/Librairies

AF12198 is a selective receptor antagonist to the human cytokine, type 1 interleukin-1 (IL-1) and thus blocks IL-1β signalling. AF12198 can inhibit IL-1-induced IL-8 production by human dermal fibroblasts and IL-1-induced intercellular adhesion molecule-1 (ICAM-1) expression by endothelial cells. AF12198 also blocks IL-1 induction of IL-6 and down regulates IL-6 induction in monkeys. AF12198 does not bind the human type II IL-1 receptor, or the murine type I IL-1 receptor. IL-1 influences a wide range of immune and inflammatory responses. Sustained expression of even low levels of IL-1 can be harmful in chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

 

Technical specification

 KD20 peptide Sequence : Ac-FEWTPGWYQJYALPL-NH2, J is L-azetidine-2-carboxylic acid
 KD20 peptide MW : 1.895.9 g/mol
 KD20 peptide Purity : > 95%
 KD20 peptide Counter-Ion : TFA Salts
Peptide library synthesis KD20 peptide Delivery format : Lyophilized

Price

 

Product Size Price €
Price $
CRB1001289-0.5 mg 0.5 mg 282 € 226 $
CRB1001289-1 mg 1 mg 385 € 308 $
CRB1001289-5 mg 5 mg 815 € 652 $
CRB1001289-10 mg 10 mg 1111 € 889 $
CRB1001289-

For Bulk Orders